Advances in oncologic imaging

Nature reviews. Clinical oncology, 2012

Over the past 120 years, the discipline of oncology has evolved so that a multitude of anatomical and increasingly complex functional imaging techniques are now applicable in both clinical and research platforms. This Timeline article revisits the achievements of the pioneer techniques in cancer imaging, discusses how these techniques have changed over time, provides some examples of clinical importance, and ventures to explain how imaging will remodel the future of modern oncology.

BJR|Open

Journal of Clinical Medicine, 2021

Molecular imaging and therapy play an increasingly important role in the field of “precision medicine” as an emergent prospect for management of the cancerous disease [...]

Academic Radiology, 2000

Seminars in Oncology, 2011

Medicine, 2008

Nature reviews. Clinical oncology, 2012

The National Cancer Institute (NCI) has a long-standing interest in evaluating and using the known advantages of molecular and functional imaging, as well as assessing the potential of novel imaging agents and modalities, to improve clinical cancer research and cancer care. In this Perspectives article, I discuss the strategies and resources being used by the NCI to foster and enhance these evaluations. Although resource and logistical challenges abound in successfully mounting these trials, many examples exist of real and potential solutions to improve the clinical evaluation process for imaging agents and modalities in the USA and in international collaborations.

Acta bio-medica : Atenei Parmensis, 2008

To review the current radiological methodologies and guidelines for staging and followup in oncology, and to give a perspective based on the available new technologies in oncologic radiology. The literature on cancer radiologic quantification in diagnostic phase and follow-up has been reviewed. The main concepts and guidelines (official and non-official) have been extracted taking into account the period of publication and the available technology. The current World Health Organization (WHO) and Response Evaluation Criteria In Solid Tumors (RECIST) guidelines have been critically evaluated on the basis of technical literature on quantitative radiology applied to oncology. Pitfalls of previous and current guidelines have been exploited on the basis of currently available techniques for quantification. Errors due to operator, scanner, software, and measurement technique inconsistency are all together far more relevant than the recognized thresholds applied for detecting therapeutic re...

2015

This article and updated information are available at:

Cancer Imaging